1.
Facon T, Moreau P, Baker R, Min C-K, Leleu X, Mohty M, Karlin L, Armstrong NM, Tekle C, Schwab S, Risse M-L, Martin T. Isatuximab plus carfilzomib and dexamethasone in patients with early <i>versus</i&gt; late relapsed multiple myeloma: IKEMA subgroup analysis. haematol [Internet]. 2024Feb.1 [cited 2024May25];109(2):604-16. Available from: https://haematologica.org/article/view/haematol.2023.283073